Mergers & Acquisitions - Generics, Perrigo


Current filters:


Popular Filters

Perrigo acquires ophthalmic portfolio from Fera Pharma for initial $93 million


Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed…

Fera PharmaceuticalsGenericsMergers & AcquisitionsOphthalmicsPerrigo

Perrigo acquires UK drugmaker Rosemont for £180 million


USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition…

GenericsMergers & AcquisitionsPerrigoPharmaceuticalRosemont Pharmaceuticals

Perrigo buys full control of Cobrek Pharma for about $45 million


US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger…

Cobrek PharmaceuticalsGenericsMergers & AcquisitionsPerrigoPharmaceutical

Impax in deal with Perrigo; Cipla eyes South Africa acquisition


Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Back to top